# MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

> **NCT06543082** · PHASE4 · RECRUITING · sponsor: **CHA University** · enrollment: 490 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Colchicine 0.6 mg

## Key facts

- **NCT ID:** NCT06543082
- **Lead sponsor:** CHA University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 490 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06543082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06543082, "MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06543082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*